You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

personalized neoantigen cancer vaccine

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Follicular Lymphoma Trial in Boston (Rituximab, Neo Vax, Pembrolizumab)

Recruiting
  • Follicular Lymphoma
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 14, 2022

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Kidney Cancer Trial in Boston (NeoVax, Ipilimumab)

Recruiting
  • Kidney Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Mar 22, 2022

Pancreatic Cancer, Pancreatic Carcinoma Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Completed
  • Pancreatic Cancer
  • Pancreatic Carcinoma
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Advanced Malignant Solid Tumor Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Active, not recruiting
  • Advanced Malignant Solid Tumor
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Sir Run Run Shaw Hospital
Nov 15, 2021

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023

Posto Perative Hepatocellular Carcinoma Trial (Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I

Not yet recruiting
  • Posto Perative Hepatocellular Carcinoma
  • Neoantigen mRNA Personalised Cancer vaccine in combination with Stintilimab I njection
  • (no location specified)
Feb 27, 2023

Refractory Tumor, Solid Tumor Trial in Kaohsiung, Tainan (Dendritic Cell Vaccine, Lenvatinib, Nivolumab)

Not yet recruiting
  • Refractory Tumor
  • Solid Tumor
  • Dendritic Cell Vaccine
  • +2 more
  • Kaohsiung, Taiwan
  • +2 more
Mar 2, 2023

Cancer, Solid Tumor Trial in San Francisco (Personalized Synthetic Long Peptide Vaccine)

Enrolling by invitation
  • Cancer
  • Solid Tumor
  • Personalized Synthetic Long Peptide Vaccine
  • San Francisco, California
    Quest Clinical Research
Feb 20, 2023

Resectable Esophageal Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Esophageal Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital of Zhejiang University
Mar 23, 2022

Gastric Cancer, Esophageal Cancer, Liver Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Recruiting
  • Gastric Cancer
  • +2 more
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, Beijing, China
    PLA General Hospital
Jan 27, 2022

Gastric Cancer Trial in Beijing (neoantigen tumor vaccine with or without PD-1/L1)

Not yet recruiting
  • Gastric Cancer
  • neoantigen tumor vaccine with or without PD-1/L1
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital,
Jan 26, 2022

Advanced Malignant Solid Tumor Trial in Hangzhou (biological, other, drug, procedure)

Recruiting
  • Advanced Malignant Solid Tumor
  • iNeo-Vac-P01
  • +3 more
  • Hangzhou, Zhejiang, China
    Run Run Shaw Hospital Affiliated to Zhejiang University School o
Apr 25, 2021

Resectable Pancreatic Cancer Trial in Hangzhou (iNeo-Vac-P01, GM-CSF)

Recruiting
  • Resectable Pancreatic Cancer
  • iNeo-Vac-P01
  • GM-CSF
  • Hangzhou, Zhejiang, China
    Zhejiang Provincial People's Hospital
Nov 15, 2021

Carcinoma, Melanoma, Bladder Cancer Trial in Chengdu (Tumor antigen-sensitized DC vaccine and their sensitized T cells

Not yet recruiting
  • Carcinoma
  • +3 more
  • Tumor antigen-sensitized DC vaccine and their sensitized T cells subcutaneous administration
  • Chengdu, Sichuan, China
    West China Hospital
Feb 10, 2022

Melanoma Trial in Boston (Poly-ICLC, Peptides)

Completed
  • Melanoma
  • Poly-ICLC
  • Peptides
  • Boston, Massachusetts
  • +1 more
Dec 7, 2020

Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)

Completed
  • Urothelial/Bladder Cancer, Nos
  • New York, New York
    Icahn School of Medicine at Mount Sinai
Mar 7, 2022

Non Small Cell Lung Cancer, Colorectal Cancer, Gastroesophageal Adenocarcinoma Trial in Australia, United States (GRT-C901,

Active, not recruiting
  • Non Small Cell Lung Cancer
  • +3 more
  • GRT-C901
  • +3 more
  • Phoenix, Arizona
  • +10 more
Aug 31, 2021

Advanced Malignant Solid Tumors Trial in Nanchang (Neoantigen peptide vaccine, Neoantigen-based DC immune preparation)

Not yet recruiting
  • Advanced Malignant Solid Tumors
  • Neoantigen peptide vaccine
  • Neoantigen-based DC immune preparation
  • Nanchang, Jiangxi, China
    First Affiliated Hospital of Nanchang University
Mar 1, 2023

Pancreatic Cancer, Pancreas Cancer, Cancer of the Pancreas Trial in Baltimore, Saint Louis (biological, device, procedure)

Active, not recruiting
  • Pancreatic Cancer
  • +2 more
  • Personalized neoantigen DNA vaccine
  • +2 more
  • Baltimore, Maryland
  • +1 more
Sep 15, 2021

Unmethylated Glioblastoma Trial in Saint Louis (Personalized Neoantigen DNA vaccine, Retifanlimab, TDS-IM v 2.0 electroporation

Not yet recruiting
  • Unmethylated Glioblastoma
  • Personalized Neoantigen DNA vaccine
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Feb 14, 2023

Non Small Cell Lung Cancer, Colorectal Cancer, Pancreatic Cancer Trial in United States (GRT-C903, GRT-R904, nivolumab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +4 more
  • GRT-C903
  • +3 more
  • Phoenix, Arizona
  • +13 more
Jan 30, 2023

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Non Small Cell Lung Cancer Trial in Amsterdam, Groningen, Rotterdam (FRAME-001 personalized vaccine)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • FRAME-001 personalized vaccine
  • Amsterdam, Netherlands
  • +2 more
Aug 9, 2021